V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005692 | 310002666 | 1.8 | 68 | Palliative (P) | 2017-10-08 | 2017-10-08 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | 310020942 | IRINOTECAN + MDG |
| 310005693 | 310002667 | 1.6 | 60 | Palliative (P) | 2018-02-21 | 2018-02-24 | MELPHALAN | 02 | N | 310021565 | SUNITINIB |
| 310005694 | 310002668 | 1.64 | 58.8 | Palliative (P) | 2018-04-27 | 2018-04-30 | Ifosfamide PVI 1g/m2 14day | N | N | 310021650 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005695 | 310002669 | 1.68 | 0 | Palliative (P) | 2017-07-08 | 2017-07-09 | Sunitinib | 02 | N | 310022131 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005696 | 310007099 | 1.85 | 0 | Palliative (P) | 2016-06-19 | 2016-06-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 310022160 | DHAP |
| 310005697 | 310002670 | null | 63.2 | null | 2018-01-28 | 2018-02-18 | Bevacizumab 7.5mg/kg | N | N | 310022924 | FEC |
| 310005698 | 310007100 | null | 0 | Palliative (P) | 2018-03-09 | 2018-04-11 | R GCVP | 02 | N | 310023141 | CISPLATIN + PEMETREXED |
| 310005699 | 310002671 | 0 | 76 | Palliative (P) | 2015-12-15 | 2015-12-15 | Enzalutamide | Y | N | 310023169 | SELPAC TRIAL |
| 310005700 | 310007101 | null | 78 | Neo-adjuvant (N) | null | 2018-11-08 | VINCRISTINE | N | null | 310023532 | METHOTREXATE |
| 310005701 | 310002672 | 1.71 | null | Palliative (P) | 2016-08-18 | 2016-09-10 | Doxorubicin + Olaratumab | 02 | N | 310023683 | CARBOPLATIN + VINORELBINE |
| 310005702 | 310002673 | 1.71 | null | Palliative (P) | 2015-07-12 | 2015-07-20 | DHAP | 2 | N | 310023817 | LANREOTIDE |
| 310005703 | 310002674 | 1.78 | null | Adjuvant (A) | 2016-06-20 | 2016-06-20 | FEC | 2 | N | 310024083 | MELPHALAN |
| 310005704 | 310002675 | 1.63 | 99.4 | Curative (C) | 2016-03-03 | 2016-03-29 | CRIZOTINIB | 02 | N | 310024088 | BEVACIZUMAB |
| 310005705 | 310002676 | null | 106 | Palliative (P) | 2015-05-25 | 2015-05-25 | Cetuximab + Radiotherapy Maint | N | N | 310024186 | OCTREOTIDE |
| 310005706 | 310002676 | 1.66 | 53.2 | Palliative (P) | 2015-06-29 | 2015-07-01 | Cisplatin + Etoposide + RT | Y | N | 310024186 | CLADRIBINE |
| 310005707 | 310002676 | 1.68 | null | null | 2018-08-24 | 2018-08-24 | Alemtuzumab(INTRAVENOUS) | N | N | 310024186 | CISPLATIN + FLUOROURACIL + RT |
| 310005708 | 310002676 | null | null | null | 2018-12-14 | 2018-12-30 | Trabectedin | N | N | 310024186 | BEP |
| 310005709 | 310002677 | 1.72 | 64.2 | Palliative (P) | 2019-09-04 | 2019-09-10 | Busulfan Oral | 02 | N | 310024798 | INTERFERON |
| 310005710 | 310007103 | 1.56 | 58.8 | Palliative (P) | 2015-11-12 | 2015-11-13 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310024845 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 310005711 | 310002678 | 1.69 | 91 | Palliative (P) | 2016-07-04 | 2016-07-06 | DABRAFENIB + TRAMETINIB | 02 | N | 310025128 | DABRAFENIB |
| 310005712 | 310002679 | 1.6 | 75 | Disease modification (D) | 2019-08-17 | 2019-09-01 | Temozolomide + RT | N | N | 310025150 | ALEMTUZUMAB |
| 310005713 | 310002679 | 1.69 | null | null | 2014-01-11 | 2014-01-13 | CETUXIMAB | N | N | 310025150 | MPV |
| 310005714 | 310002679 | 1.71 | 73.8 | null | 2016-09-17 | 2016-09-18 | CVP | N | N | 310025150 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005715 | 310002679 | 1.9 | 110 | Adjuvant (A) | 2015-12-25 | 2015-12-26 | R GCVP | 02 | N | 310025150 | ETOPOSIDE |
| 310005716 | 310002680 | 1.73 | 57 | Curative (C) | 2019-04-08 | 2019-04-15 | Cisplatin + Fluorouracil + RT 5day | N | null | 310002433 | DOCETAXEL |
| 310005717 | 310002680 | 1.62 | 58.3 | Curative (C) | 2017-07-30 | 2017-07-30 | Trabectedin | null | N | 310002433 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005718 | 310002681 | null | 83.7 | Curative (C) | 2018-08-06 | 2018-09-18 | LENALIDOMIDE | 2 | Y | 310004470 | METHOTREXATE |
| 310005719 | 310002682 | 1.64 | 61.8 | Curative (C) | 2015-11-06 | 2015-12-06 | Bevacizumab 15mg/kg | N | N | 310005025 | FEC |
| 310005720 | 310002683 | 1.6 | 86 | Curative (C) | 2015-10-25 | 2015-10-27 | Sunitinib | N | N | 310005408 | UKALL 2011 |
| 310005721 | 310002684 | null | 68 | Palliative (P) | 2018-12-16 | 2019-01-11 | EDP | null | N | 310007069 | PAZOPANIB |
| 310005722 | 310002684 | 1.86 | 95.6 | Curative (C) | 2016-04-19 | 2016-04-19 | DABRAFENIB + TRAMETINIB | N | N | 310007069 | DA |
| 310005723 | 310002684 | 0.02 | 162.6 | Curative (C) | 2018-05-23 | 2018-06-11 | CHLVPP | 01 | N | 310007069 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005724 | 310002685 | null | 63.4 | Curative (C) | 2018-10-13 | 2018-11-10 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | 310019348 | CVP R |
| 310005725 | 310002686 | null | 49.2 | Curative (C) | 2018-01-11 | 2018-01-24 | Methotrexate intrathecal | 2 | Y | 310020717 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005726 | 310002687 | 1.78 | 52.5 | Curative (C) | 2019-09-06 | 2019-09-06 | Carboplatin + Vinorelbine IV | 02 | N | 310021764 | BEVACIZUMAB |
| 310005727 | 310002688 | 1.67 | null | Disease modification (D) | 2013-06-03 | 2013-10-26 | POUT TRIAL | 02 | N | 310022613 | CARBOPLATIN + RT |
| 310005728 | 310002688 | 1.5 | 72.5 | Curative (C) | 2015-06-29 | 2015-08-08 | UKALL14- Ph 2 Induction | N | N | 310022613 | FEC + DOCETAXEL |
| 310005729 | 310002689 | 1.68 | 125 | null | 2016-10-01 | 2016-10-01 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 310024445 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 310005730 | 310002690 | 1.8 | 98 | Palliative (P) | 2018-02-22 | 2018-03-02 | DABRAFENIB | 2 | N | 310001788 | IVAC |
| 310005731 | 310002691 | 1.7 | 88 | Adjuvant (A) | 2019-09-25 | 2019-10-12 | Bevacizumab | N | N | 310002808 | OXALIPLATIN |
| 310005732 | 310002691 | 1.48 | 85 | Curative (C) | 2018-01-17 | 2018-01-17 | Capecitabine + Cisplatin + RT | 02 | N | 310002808 | EC |
| 310005733 | 310002692 | 1.54 | null | null | null | 2018-04-30 | Chlorambucil | N | N | 310023725 | BEP |
| 310005734 | 310002692 | 0 | 96 | Palliative (P) | 2017-03-03 | 2017-03-14 | IVA | N | N | 310023725 | CVD |
| 310005735 | 310002693 | 1.57 | 62 | Neo-adjuvant (N) | 2017-02-15 | 2017-02-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 310000272 | CARBOPLATIN + PACLITAXEL |
| 310005736 | 310002694 | 1.64 | 60.5 | null | 2016-11-16 | 2016-11-17 | Carboplatin AUC 2 - 5 | N | N | 310000365 | CARBOPLATIN |
| 310005737 | 310002695 | null | 91.6 | Palliative (P) | 2015-07-04 | 2015-07-13 | CARBOPLATIN + PACLITAXEL | N | N | 310000978 | CARBOPLATIN + PACLITAXEL |
| 310005738 | 310002697 | 1.59 | 75 | Palliative (P) | 2018-07-12 | 2018-07-22 | Paclitaxel (2 or 3 weekly) | N | N | 310002421 | PACLITAXEL |
| 310005739 | 310002698 | 1.59 | 58 | Palliative (P) | 2016-12-19 | 2017-01-09 | Paclitaxel 7 day | 02 | N | 310003705 | PACLITAXEL |
| 310005740 | 310002699 | null | 68.3 | Curative (C) | 2015-11-05 | 2015-11-26 | Carboplatin AUC 2 - 5 | N | N | 310003927 | CARBOPLATIN |
| 310005741 | 310002699 | null | 61.2 | Curative (C) | 2015-08-29 | 2015-10-25 | Paclitaxel 7 day | N | null | 310003927 | PACLITAXEL |